Impact of Multidisciplinary Review of Drug Prescriptions on Patient Safety in a Residence for Dependent Elderly
NCT ID: NCT02118259
Last Updated: 2015-05-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
49 participants
INTERVENTIONAL
2014-05-31
2015-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Medication Reconciliation at Discharge on Potentially Inappropriate Medications in the Elderly : Community-hospital Coordination
NCT03415113
Adverse Drug Reactions in Older Subjects
NCT03623542
Serious Adverse Drug Reaction and Their Preventability
NCT02888834
Impact of Mulstidisciplinary Medication Assessment Review in Surgery Departments
NCT03827031
Impact of Collaborative Pharmaceutical Care on Hospital Admission Drug Prescriptions for Patients 65 Years of Age and Older
NCT02598115
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A. the number of patients with at least one potentially inappropriate drug prescribed
B. the number of hospitalizations
C. death rate
D. the number of falls per patient and the rate of fallers
E. qualitative criteria describing the drug review
F. associated care costs
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
The study population
See inclusion and exclusion criteria.
Intervention: Before-after study
Before-after study
The before-after study is composed of a first observational phase followed by a proactive phase, and then finally by a second observational phase.
The first observational phase corresponds to retrospective data-collecting for the information necessary for calculating the baseline ADE geriatric risk score.
The proactive phase corresponds to a multidisciplinary review of drug prescriptions (especially long-term drugs) for all included patients in the residence.
During the second observational phase, the same data as in the first observational phase will be collected a second time.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Before-after study
The before-after study is composed of a first observational phase followed by a proactive phase, and then finally by a second observational phase.
The first observational phase corresponds to retrospective data-collecting for the information necessary for calculating the baseline ADE geriatric risk score.
The proactive phase corresponds to a multidisciplinary review of drug prescriptions (especially long-term drugs) for all included patients in the residence.
During the second observational phase, the same data as in the first observational phase will be collected a second time.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The patient must be insured or beneficiary of a health insurance plan
* The patient is available for 6 months of follow-up
* The patient has resided at the Nîmes University Hospital Residence for Dependent Elderly for at least the past 6 months
Exclusion Criteria
* The patient is in an exclusion period determined by a previous study
* The patient is under judicial protection
* The patient (or his/her legal representative) refuses to sign the consent
* It is impossible to correctly inform the patient (or his/her legal representative)
* The patient has resided at the Nîmes University Hospital Residence for Dependent Elderly for less than 6 months
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nīmes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Géraldine Leguelinel, Pharm-D
Role: STUDY_DIRECTOR
Centre Hospitalier Universitaire de Nîmes
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHRU de Nîmes - Centre de Gérontologie de Serre Cavalier
Nîmes, , France
CHRU de Nîmes - Hôpital Universitaire Carémeau
Nîmes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013-A01590-45
Identifier Type: OTHER
Identifier Source: secondary_id
LOCAL/2013/GL-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.